IDRA-21 is a benzothiadiazine derivative that acts as a positive allosteric modulator of the AMPA receptor. This chiral compound is used in research to study AMPA receptor modulation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 22503-72-6
2-Fluoro-5-nitrophenol
research compound
3-(4-hydroxy-3-methylphenyl)propanenitrile
research compound
2-Bromo-6-fluorobenzoic acid
research compound
3-(Trifluoromethoxy)bromobenzene
research compound
Altizide
pharmaceutical raw material
Hydrochlorothiazide
pharmaceutical raw material
HYDROCHLOROTHIAZIDE-3,3-D2
pharmaceutical raw material
Trichlormethiazide
pharmaceutical raw material
7-chloro-3-methyl-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine 1,1-dioxide
VZRNTCHTJRLTMU-UHFFFAOYSA-N
CC1NC2=C(C=C(C=C2)Cl)S(=O)(=O)N1